Top Markets
Coin of the day
American CryoStem Corporation American CryoStem Corporation

American CryoStem Corporation

CRYO
Rankning i aktier #42083
American CryoStem Corporation (ACSC) specializes in the development,... American CryoStem Corporation (ACSC) specializes in the development, commercialization, and licensing of technologies derived from adipose (fat) tissue, primarily for applications within regenerative and personalized medicine. Among its key offerings is the CELLECT system, designed to streamline tissue sample collection, transportation, and storage for medical practitioners. The company also provides the ATGRAFT service, a comprehensive solution for harvesting, processing, and preserving adipose tissue, enabling physicians to offer patients versatile options for tissue products and cellular banking. Complementing these are ATCELL, a line of proprietary adipose-derived stem cells, and ACSelerat cell culture media, specifically formulated to promote the growth of human stromal cells. Furthermore, American CryoStem extends its expertise through contract manufacturing services for specific formulations, including Autokine-CM, an anti-aging topical product, and a unique autologous skin care range. Founded in 1987, American CryoStem Corporation is headquartered in Eatontown, New Jersey.
Aktiekurs
$0.0001
Senast synkroniserad: 2024-04-02
Marknadsvärde
$5.03K
Förändring (1 dag)
0.00%
Förändring (1 år)
0.00%
Land
US
Handel American CryoStem Corporation (CRYO)

Kategori

Utdelningsavkastning för American CryoStem Corporation (CRYO)
Utdelningsavkastningen (TTM) för American CryoStem Corporation (aktiesymbol: CRYO) per 2026 är: 0
Genomsnittlig utdelningsavkastning de senaste 5 åren: 0.00%
Historik för utdelningsavkastning för American CryoStem Corporation (CRYO) från 2026 till 2026
Utdelningsavkastning i slutet av varje år (TTM)
År Utdelningsavkastning Ändra
Inte tillräckligt med data för de angivna datumen.
Utdelningsavkastning (TTM) för liknande företag eller konkurrenter